For: | Devi J, Raees A, Butt AS. Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? World J Hepatol 2022; 14(1): 158-167 [PMID: 35126845 DOI: 10.4254/wjh.v14.i1.158] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i1/158.htm |
Number | Citing Articles |
1 |
Maria Hernandez-Tejero, Samhita Ravi, Jaideep Behari, Gavin E. Arteel, Juan Pablo Arab, Ramon Bataller. High Variability on Alcohol Intake Threshold in Articles Using the MAFLD Acronym. Gastro Hep Advances 2024; 3(1): 96 doi: 10.1016/j.gastha.2023.08.016
|
2 |
Francesca Lanzaro, Stefano Guarino, Elisabetta D'Addio, Alessandra Salvatori, Josè Alberto D'Anna, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions. World Journal of Hepatology 2022; 14(6): 1087-1098 doi: 10.4254/wjh.v14.i6.1087
|
3 |
D. Yu. Venidiktova, A. V. Borsukov. Instrumental features of the differential diagnosis of metabolically associated and non-alcoholic fatty liver diseases. The Siberian Journal of Clinical and Experimental Medicine 2023; 38(2): 209 doi: 10.29001/2073-8552-2023-38-2-209-217
|
4 |
Weiwei He, Caoxin Huang, Liying Wang, Weijuan Su, Shunhua Wang, Peiying Huang, Xiaofang Zhang, Yinxiang Huang, Yan Zhao, Mingzhu Lin, Xiulin Shi, Xuejun Li. The correlation between triiodothyronine and the severity of liver fibrosis. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01228-8
|
5 |
Ghazala S Virk, Jaahnavi Vajje, Nausheen K Virk, Raam Mannam, Wajeeh Rehman, Naglaa G Ghobriel , Irfan-ud-din Mian, Muhammad Usama. Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis. Cureus 2023; doi: 10.7759/cureus.44413
|